Compare Inovio Pharmaceuticals Inc (INO) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Viking Holdings Ltd Ordinary Shares — how do they compare? Inovio Pharmaceuticals Inc trades at $1.11 (market cap $119.42M), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.29B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 303.9× Inovio Pharmaceuticals Inc's market cap, and Viking Holdings Ltd Ordinary Shares is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| INO | VIK | |
|---|---|---|
Market Cap | $119.42M | $36.29B |
Volume | 2,789,649 | 2,522,956 |
Sector | Health | Consumer Cyclical |
52-Week High | $2.65 | $108.26 |
52-Week Low | $0.66 | $57.08 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | $90.75M | $38.67B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.09, down 3.54% on the day, with a bearish technical signal driven by moving averages. The company reported a net loss of $84.95 million in 2025 on minimal revenue of $65,340, with negative profitability metrics, but has beaten EPS estimates in recent quarters. Key near-term catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107.
The investment case hinges on regulatory approval of INO-3107, with a consensus price target of $2.75 implying significant upside. However, extreme financial losses, high cash burn, and dependence on dilutive financing pose substantial risks. Analyst sentiment is cautiously optimistic but reflects high uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Viking Holdings Ltd Ordinary Shares
Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →
